MCK 📈 McKesson - Overview
Exchange: NYSE • Opening Hours • Country: United States • Currency: USD • Type: Common Stock • ISIN: US58155Q1031
MCK: Pharmaceuticals, Medical Supplies, Technology Solutions, Logistics Services
Mckesson Corporation is a leading healthcare company that provides a wide range of services in the United States and internationally. The company operates through four distinct segments, each catering to specific needs in the healthcare industry.
The U.S. Pharmaceutical segment is a major player in the distribution of pharmaceutical drugs, including branded, generic, specialty, biosimilar, and over-the-counter medications. In addition to drug distribution, this segment offers a suite of services to community-based oncology and specialty practices, including practice management, technology, clinical support, and business solutions. It also provides consulting, outsourcing, and technological services to pharmacies, as well as financial, operational, and clinical solutions to help them optimize their operations.
The Prescription Technology Solutions (RxTS) segment focuses on addressing medication challenges for patients by connecting various stakeholders in the healthcare ecosystem, including patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. This segment offers innovative solutions to improve patient outcomes, including prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services.
The Medical-Surgical Solutions segment is dedicated to providing medical-surgical supply distribution, logistics, and other services to healthcare providers, such as physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment helps healthcare providers streamline their operations and improve patient care.
The International segment operates in Europe and Canada, providing distribution and services to wholesale, institutional, and retail customers. This segment helps to expand McKesson's reach and provide its services to a broader customer base.
With a rich history dating back to 1833, McKesson Corporation is headquartered in Irving, Texas, and has established itself as a trusted partner in the healthcare industry. To learn more about the company and its services, visit their website at https://www.mckesson.com.
Additional Sources for MCK Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
MCK Stock Overview
Market Cap in USD | 68,202m |
Sector | Healthcare |
Industry | Medical Distribution |
GiC SubIndustry | Health Care Distributors |
TER | 0.00% |
IPO / Inception | 1994-11-15 |
MCK Stock Ratings
Growth 5y | 92.2 |
Fundamental | 53.1 |
Dividend | 50.8 |
Rel. Performance vs Sector | 2.01 |
Analysts | 4.11/5 |
Fair Price Momentum | 740.27 USD |
Fair Price DCF | 937.29 USD |
MCK Dividends
Dividend Yield 12m | 0.41% |
Yield on Cost 5y | 1.74% |
Dividends CAGR 5y | 7.71% |
Payout Consistency | 96.73% |
MCK Growth Ratios
Growth Correlation 3m | 20.1% |
Growth Correlation 12m | 50.8% |
Growth Correlation 5y | 98.7% |
CAGR 5y | 33.27% |
CAGR/Mean DD 5y | 6.30 |
Sharpe Ratio 12m | 1.15 |
Alpha vs SP500 12m | 11.92 |
Beta vs SP500 5y weekly | 0.74 |
Volatility GJR Garch 1y | 34.60% |
Current Volume | 484.8k |
Average Volume 20d | 988.1k |
As of November 21, 2024, the stock is trading at USD 621.14 with a total of 484,842 shares traded.
Over the past week, the price has changed by -0.55%, over one month by +22.19%, over three months by +13.38% and over the past year by +37.80%.
Partly, yes. Based on ValueRay Fundamental Analyses, McKesson (NYSE:MCK) is currently (November 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 53.05 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MCK as of November 2024 is 740.27. This means that MCK is currently undervalued and has a potential upside of +19.18% (Margin of Safety).
- Strong Buy: 9
- Buy: 3
- Hold: 5
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, MCK McKesson will be worth about 810.2 in November 2025. The stock is currently trading at 621.14. This means that the stock has a potential upside of +30.44%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 583.5 | -6.1% |
Analysts Target Price | 486.3 | -21.7% |
ValueRay Target Price | 810.2 | 30.4% |